| abstract |
This article discloses that compounds having the structure of Formula I and their pharmaceutically suitable salts, esters, and prodrugs can be used as antibacterial tricyclic gyrase inhibitors. In addition, the type of tricyclic gyrase inhibitor compound is also disclosed herein.nn n n It also covers related pharmaceutical compositions, uses, and methods of making these compounds. |